search
Back to results

Prevention of Type II Endoleaks During Endovascular Treatment of Abdominal Aortic Aneurysm: Endovascular Treatment Versus Combination With Coil Embolisation of the Aneurysmal Sac (SCOPE1)

Primary Purpose

Abdominal Aortic Aneurysm

Status
Completed
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
EVAR without coils embolization/ Coils embolization during EVAR
Sponsored by
Centre Chirurgical Marie Lannelongue
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Abdominal Aortic Aneurysm focused on measuring Vascular surgery, Abdominal Aortic aneurysm, endovascular

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Age > 18 years
  • Carrying a sub-renal AAA with a diameter of at least 5 cm at a rate of growth or greater 1cm/an diameter (according to Haute Autorité de Santé (HAS) recommendations toE VAR treatment),
  • Patients with high risk of type II endoleak (clouding of an aortic aneurysm sac by collateral branch), respondents with at least one of the following criteria on the scanner to be included:

    • The presence of a pair of permeable lumbar arteries.
    • The presence of a patent inferior mesenteric artery.

Exclusion Criteria:

  • Sub renal Collet <10 mm
  • Angulated > 60 °
  • No collateral arising from the aneurysmal sac
  • Iliac aneurysms associated
  • Ruptured AAA
  • Pregnant Women
  • Lack of consent
  • Lack of social security

Sites / Locations

  • Hopital Henri Mondor - APHP
  • Centre Chirurgical MarieLannelongue
  • Institut Mutualiste Montsouris

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Experimental

Arm Label

EVAR

Coil embolization during EVAR

Arm Description

Endovascular repair of an Abdominal Aortic Aneurysm

coil embolization during Endovascular repair

Outcomes

Primary Outcome Measures

Evaluation at one month the presence or absence of endoleak type II in all patients for each group by Computer Tomography and Doppler.

Secondary Outcome Measures

• Evaluation at 6, 12 and 24 months by CT and doppler: -The rate of type II endoleak
• Mortality and morbidity .
• Number of additional procedures -endovascular -surgical
• Complications of endovascular procedures away from the EVAR -Thrombosis of leg -Limb occlusion -Evolution of the aneurysmal neck
• Monitoring of renal function (creatinine clearance).
• Evaluation at 6, 12 and 24 months by CT and doppler: -Measurement of the maximum transverse aneurysm diameter
• Evaluation at 6, 12 and 24 months by CT and doppler: -volumetric measurement of the sac aneurysmal

Full Information

First Posted
May 17, 2013
Last Updated
January 21, 2020
Sponsor
Centre Chirurgical Marie Lannelongue
Collaborators
Institut Mutualiste Montsouris, Henri Mondor University Hospital, Unité de Recherche Clinique du Centre chirurgical marie Lannelongue
search

1. Study Identification

Unique Protocol Identification Number
NCT01878240
Brief Title
Prevention of Type II Endoleaks During Endovascular Treatment of Abdominal Aortic Aneurysm: Endovascular Treatment Versus Combination With Coil Embolisation of the Aneurysmal Sac
Acronym
SCOPE1
Official Title
Prevention of Type II Endoleaks During Endovascular Treatment of Abdominal Aortic Aneurysm: Endovascular Treatment Versus Combination With Coil Embolisation of the Aneurysmal Sac
Study Type
Interventional

2. Study Status

Record Verification Date
April 2019
Overall Recruitment Status
Completed
Study Start Date
May 2013 (Actual)
Primary Completion Date
April 2017 (Actual)
Study Completion Date
May 2019 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Centre Chirurgical Marie Lannelongue
Collaborators
Institut Mutualiste Montsouris, Henri Mondor University Hospital, Unité de Recherche Clinique du Centre chirurgical marie Lannelongue

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Abdominal aortic aneurysms (AAAs) continue to be a leading cause of death in older age groups. In the 60-85 year-old population, AAA represents the 14th-leading cause of death. Federal funding through Medicare has been allocated for early detection using abdominal ultrasound screening programs. Despite these more aggressive screening programs and concerted efforts by surgeons for timely repair, the incidence of ruptured AAA has continued to increase. Endovascular aneurysm repair (EVAR) has been the most common type of repair since 2006. Multiple studies reflecting decreased perioperative morbidity and mortality over open repair make this an attractive option for patients. EVAR requires more intensive follow-up than standard open surgical repair, however. Secondary interventions are more common to maintain "seal" of the endograft within the aorta and subsequent exclusion of the aneurysmal component. The term endoleak is specific to EVAR, and describes the primary means by which endografts fail. Type I endoleaks occur because of inadequate graft seal proximally or distally, resulting in perigraft flow and aneurysm sac pressurization. Type II endoleaks occur when branch arteries arising from the aneurysmal aorta back-bleed into the aneurysm sac due to collateral flow. Type III endoleaks occur when flow persists between segments of a modular graft. Type IV endoleaks occur when flow persists through endograft material (graft porosity). Type V endoleaks have also been called "endotension", and occur when pressurization of the sac occurs in the absence of any demonstrable endoleak. Type I and Type III endoleaks are most concerning for rupture, although persistent Type II endoleaks can also lead to aneurysm rupture and premature death. The most common method of EVAR follow-up is computed tomographic angiography (CTA). These studies allow accurate measurement of aneurysm sac diameters and volumes. They also are highly sensitive and specific for endoleaks. Type II endoleaks are treated if they remain persistent and are present in the setting of aneurysm sac enlargement. Type I and III endoleaks are immediately treated when identified. Type IV endoleaks are rarely seen with current endograft technology.
Detailed Description
Study Objectives: The purpose of the current study is to compare the level of endoleaks between group 1 and 2 at 1, 6, 12 and 24 months. Study Design Prospective interventional study, multicenter, open, randomized trial comparing the type II endoleak level in patients who benefited the endovascular AAA repair (group 1: without coils) versus combination with coil embolization of the aneurysmal sac (group II: with coils). The choice of treatment is randomized.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Abdominal Aortic Aneurysm
Keywords
Vascular surgery, Abdominal Aortic aneurysm, endovascular

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
100 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
EVAR
Arm Type
Active Comparator
Arm Description
Endovascular repair of an Abdominal Aortic Aneurysm
Arm Title
Coil embolization during EVAR
Arm Type
Experimental
Arm Description
coil embolization during Endovascular repair
Intervention Type
Procedure
Intervention Name(s)
EVAR without coils embolization/ Coils embolization during EVAR
Other Intervention Name(s)
Coil embolization during endovascular Aortic Abdominal Aneurysm repair
Primary Outcome Measure Information:
Title
Evaluation at one month the presence or absence of endoleak type II in all patients for each group by Computer Tomography and Doppler.
Time Frame
1 month
Secondary Outcome Measure Information:
Title
• Evaluation at 6, 12 and 24 months by CT and doppler: -The rate of type II endoleak
Time Frame
6, 12 and 24 months
Title
• Mortality and morbidity .
Time Frame
1, 6, 12 and 24 months
Title
• Number of additional procedures -endovascular -surgical
Time Frame
1, 6, 12 and 24 months
Title
• Complications of endovascular procedures away from the EVAR -Thrombosis of leg -Limb occlusion -Evolution of the aneurysmal neck
Time Frame
1, 6, 12 and 24 months
Title
• Monitoring of renal function (creatinine clearance).
Time Frame
1, 6, 12 and 24 months
Title
• Evaluation at 6, 12 and 24 months by CT and doppler: -Measurement of the maximum transverse aneurysm diameter
Time Frame
6, 12 and 24 months
Title
• Evaluation at 6, 12 and 24 months by CT and doppler: -volumetric measurement of the sac aneurysmal
Time Frame
6, 12 and 24 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Age > 18 years Carrying a sub-renal AAA with a diameter of at least 5 cm at a rate of growth or greater 1cm/an diameter (according to Haute Autorité de Santé (HAS) recommendations toE VAR treatment), Patients with high risk of type II endoleak (clouding of an aortic aneurysm sac by collateral branch), respondents with at least one of the following criteria on the scanner to be included: The presence of a pair of permeable lumbar arteries. The presence of a patent inferior mesenteric artery. Exclusion Criteria: Sub renal Collet <10 mm Angulated > 60 ° No collateral arising from the aneurysmal sac Iliac aneurysms associated Ruptured AAA Pregnant Women Lack of consent Lack of social security
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Dominique FABRE, Vascular surgeon
Organizational Affiliation
Centre Chirurgical Marie Lannelongue
Official's Role
Principal Investigator
Facility Information:
Facility Name
Hopital Henri Mondor - APHP
City
Creteil
State/Province
Ile De France
ZIP/Postal Code
94000
Country
France
Facility Name
Centre Chirurgical MarieLannelongue
City
Le Plessis Robinson
State/Province
Ile De France
ZIP/Postal Code
92350
Country
France
Facility Name
Institut Mutualiste Montsouris
City
Paris
State/Province
Ile De France
ZIP/Postal Code
75014
Country
France

12. IPD Sharing Statement

Citations:
PubMed Identifier
23171095
Citation
Lederle FA, Freischlag JA, Kyriakides TC, Matsumura JS, Padberg FT Jr, Kohler TR, Kougias P, Jean-Claude JM, Cikrit DF, Swanson KM; OVER Veterans Affairs Cooperative Study Group. Long-term comparison of endovascular and open repair of abdominal aortic aneurysm. N Engl J Med. 2012 Nov 22;367(21):1988-97. doi: 10.1056/NEJMoa1207481.
Results Reference
result
PubMed Identifier
22511690
Citation
Jackson RS, Chang DC, Freischlag JA. Comparison of long-term survival after open vs endovascular repair of intact abdominal aortic aneurysm among Medicare beneficiaries. JAMA. 2012 Apr 18;307(15):1621-8. doi: 10.1001/jama.2012.453.
Results Reference
result
PubMed Identifier
23475697
Citation
Stather PW, Sidloff D, Dattani N, Choke E, Bown MJ, Sayers RD. Systematic review and meta-analysis of the early and late outcomes of open and endovascular repair of abdominal aortic aneurysm. Br J Surg. 2013 Jun;100(7):863-72. doi: 10.1002/bjs.9101. Epub 2013 Mar 8.
Results Reference
result
PubMed Identifier
23384494
Citation
Piazza M, Frigatti P, Scrivere P, Bonvini S, Noventa F, Ricotta JJ 2nd, Grego F, Antonello M. Role of aneurysm sac embolization during endovascular aneurysm repair in the prevention of type II endoleak-related complications. J Vasc Surg. 2013 Apr;57(4):934-41. doi: 10.1016/j.jvs.2012.10.078. Epub 2013 Feb 4.
Results Reference
result
PubMed Identifier
21478500
Citation
Schanzer A, Greenberg RK, Hevelone N, Robinson WP, Eslami MH, Goldberg RJ, Messina L. Predictors of abdominal aortic aneurysm sac enlargement after endovascular repair. Circulation. 2011 Jun 21;123(24):2848-55. doi: 10.1161/CIRCULATIONAHA.110.014902. Epub 2011 Apr 10. Erratum In: Circulation. 2012 Jan 17;125(2):e266.
Results Reference
result
PubMed Identifier
33342658
Citation
Fabre D, Mougin J, Mitilian D, Cochennec F, Garcia Alonso C, Becquemin JP, Desgranges P, Allaire E, Hamdi S, Brenot P, Bourkaib R, Haulon S. Prospective, Randomised Two Centre Trial of Endovascular Repair of Abdominal Aortic Aneurysm With or Without Sac Embolisation. Eur J Vasc Endovasc Surg. 2021 Feb;61(2):201-209. doi: 10.1016/j.ejvs.2020.11.028. Epub 2020 Dec 17.
Results Reference
derived

Learn more about this trial

Prevention of Type II Endoleaks During Endovascular Treatment of Abdominal Aortic Aneurysm: Endovascular Treatment Versus Combination With Coil Embolisation of the Aneurysmal Sac

We'll reach out to this number within 24 hrs